The key metric is glass transition temperature
The institute is Federal Drug Administration (FDA), (2021, accessed 12 March 2025).
Studies have documented reductions in cortisol levels of 20-40% following DSIP administration, with normalization of the diurnal cortisol rhythm that is often disrupted in chronic stress states and sleep disorders
An independent association between the GPX4 gene polymorphism and the risk of CS was assessed using multiple logistic regression analysis after adjusting for potential confounding factors such as sex, BMI, blood pressure and antihypertensive medication use
However, for noticeable changes in muscle mass or significant weight loss, a longer period of consistent supplementation, coupled with diet and exercise, may be necessary